These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7174855)

  • 1. Disposition of zomepirac sodium in man.
    O'Neill PJ; Yorgey KA; Renzi NL; Williams RL; Benet LZ
    J Clin Pharmacol; 1982 Oct; 22(10):470-6. PubMed ID: 7174855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
    Smith PC; Langendijk PN; Bosso JA; Benet LZ
    Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the pharmacokinetics and metabolism of zomepirac in man and animals.
    Muschek LD; Grindel JM
    J Clin Pharmacol; 1980 Apr; 20(4):223-9. PubMed ID: 6769977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zomepirac kinetics in healthy males.
    Nayak RK; Ng KT; Gottlieb S; Plostnieks J
    Clin Pharmacol Ther; 1980 Mar; 27(3):395-401. PubMed ID: 7357796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
    Smith PC; McDonagh AF; Benet LZ
    J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucuronidation of zomepirac in patients with cirrhosis of the liver.
    Witassek F; Bircher J; Huguenin P; Preisig R
    Hepatology; 1983; 3(3):415-22. PubMed ID: 6840687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal handling of zomepirac sodium (McN-2783-21-98) in the rat.
    O'Neill PJ; Yorgey KA; Migdalof BH; Gussin RZ
    J Pharmacol Exp Ther; 1979 Jun; 209(3):366-70. PubMed ID: 35605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics and renal handling of zomepirac in rhesus monkeys.
    O'Neill PJ; Yorgey KA; McKown LA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):665-8. PubMed ID: 7299689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-chromatographic determination of zomepirac in serum and plasma.
    Welch CL; Annesley TM; Luthra HS; Moyer TP
    Clin Chem; 1982 Mar; 28(3):481-4. PubMed ID: 7067091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of zomepirac sodium. II. Isolation and identification of the urinary metabolites in rat, mouse, rhesus monkey, and man.
    Wu WN; Weaner LE; Kalbron J; O'Neill PJ; Grindel JM
    Drug Metab Dispos; 1980; 8(5):349-52. PubMed ID: 6107234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and excretion of tolmetin in arthritic patients.
    Grindel JM; Migdalof BH; Plostnieks J
    Clin Pharmacol Ther; 1979 Jul; 26(1):122-8. PubMed ID: 445955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of zomepirac and its major metabolite zomepirac glucuronide in human plasma and urine.
    Langendijk PN; Smith PC; Hasegawa J; Benet LZ
    J Chromatogr; 1984 May; 307(2):371-9. PubMed ID: 6610684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and irreversible plasma protein binding of tolmetin in humans.
    Hyneck ML; Smith PC; Munafo A; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1988 Jul; 44(1):107-14. PubMed ID: 3390998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of the bile-exteriorized rat as a source of reactive acyl glucuronides: studies with zomepirac.
    King AR; Dickinson RG
    J Pharmacol Toxicol Methods; 1996 Nov; 36(3):131-6. PubMed ID: 8959578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism.
    Smith PC; Benet LZ; McDonagh AF
    Drug Metab Dispos; 1990; 18(5):639-44. PubMed ID: 1981713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zomepirac--aspirin interactions in man.
    Desiraju RK; Nayak RK; Pritchard JF
    J Clin Pharmacol; 1984; 24(8-9):371-80. PubMed ID: 6480878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zomepirac (Zomax, McNeil Pharmaceutical).
    McLeod DC
    Drug Intell Clin Pharm; 1981; 15(7-8):522-30. PubMed ID: 7018870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.